We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Quantum Phar. | LSE:QP. | London | Ordinary Share | GB00BRTL8Q42 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 84.2374 | 84.00 | 84.75 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
22/5/2017 13:22 | Hopefully new recent highs coming soon, in which case a quick move up to 70p looks on the cards chart-wise. | rivaldo | |
22/5/2017 10:06 | nice breakout | kemche | |
18/5/2017 09:19 | YES positivity seems clear at last to me. | hazl | |
17/5/2017 18:02 | Battyliveson.. Could not agree more.. Once the disposal of the Medication Adherence Division which is extremely low margin has been completed together with the CEO's action to increase profitability and partnerships .. the Group would be a very attractive and profitable acquisition for a bigger player.. e.g Clinigen Group.. My view (for what it is worth) is they would make an ideal fit.. Likewise I would expect Harwood Capital a major shareholder in QP to want a 300% return on its 34p capital investment in the company having rescued it from the brink... making a takeout price of £1.00 - £1.20 at some future date... All conjecture of course ! | rosejs2 | |
17/5/2017 16:51 | If his falls below 50 I may accumulate a few more. With post reorg EBITDA of 10m and a market value of 90m, it is a fairly undemanding valuation. Looks to have been reorganised in order to make it interesting as a bolt on acquisition to a bigger player. I would expect a minimum upside of 50-100% from here, with 20-30% downside if future results don't reflect the growing profitability flagged in last results statement. A good risk reward share in my view. Just a little illiquid so will need to be patient. B | battyliveson | |
16/5/2017 09:58 | Yes, A258 I THINK this is a recovery stock now. | hazl | |
15/5/2017 07:55 | I am now in at 57p, hoping to see 70p short term and then a long term run up to maybe 90p | a2584728 | |
13/5/2017 10:35 | Too late for caution I'm afraid. I can't sell now without taking a significant loss. Just have to keep the fingers crossed and be hopeful.The recent news is good though. Although I'm in no hurry to invest in any more pharma | werewolfie | |
12/5/2017 21:21 | It's a holding pattern. 2 directors are accountants and Gerrard bailed out of IDH which he joined after Vardy. The pharma lady who was the high profile joiner last year left in January. Caution | r ball | |
12/5/2017 19:04 | Hmm well the city seems to like their new strategy better than their old one. And based on recent results, it seems to be working. | werewolfie | |
12/5/2017 18:08 | They haven't learned-they've all left and it's a new Board. | r ball | |
12/5/2017 09:06 | I'm certainly confident over time this year it will head back towards the 90p highs of Summer 2016 | bigdazzler | |
12/5/2017 09:04 | Haha I bought a small amount at £1.58 but mostly at £1.28. I was tempted to buy around 40p mark but decided against. Catching a falling knife and all that | werewolfie | |
11/5/2017 10:04 | Tickling up again today, I increased holding today | ayl30 | |
10/5/2017 15:09 | Comfortably above 20,50 and 200 SMA with volume. Swift run to 70p? | aishah | |
10/5/2017 14:31 | Mm's out of patience, need to balance as mainly buys. | mustau | |
10/5/2017 13:40 | Certainly psychologically,it's great to be off the lows....hopefully... and with renewed enthusiam. | hazl | |
10/5/2017 13:32 | Feel £1 in the next month or so, holding from the lows. | mustau | |
10/5/2017 11:53 | One other thing of note. The reported Profit for last year was minus £10.85. Given that the normal profit would have been several million positive, the company has apparently taken the opportunity to do a "kitchen Sink" exercise - i.e. they have dumped a load of costs in the guise of exiting Nufarm so that will bode well for this years profit. Oh and be aware that 80% of shares are held by Institutions so given the number held by a few other individuals, including management, the trading is taking place among a relatively small number of shares/shareholders. | grosvenor11 | |
10/5/2017 11:24 | rise....," long may it continue". I'll most certainly second that. f | fillipe | |
10/5/2017 11:20 | I bought at £1.61 so I've won the dubious title of buying at highest amount! This was the darling tip at the time, great to see the rise over last few days, long may it continue. | jonboy9 | |
10/5/2017 11:03 | Circa 100p here as well.Tucked them away for the rest of this decade.Maybe break even a bit sooner than i thought at this rate lol. | chiefbrody | |
10/5/2017 10:52 | I think I'm in the lead with 158p!! Fortunately I also bought large early this year @ 43p, but the average is still suffering from that earlier cost. However it really is most heartening to see the recent upticks....currently 60.25p is the best bid showing on L2. gla f | fillipe |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions